The nurse is caring for a patient with migraine headaches. Which assessment best indicates that suma agonist, is exerting the desired therapeutic effect?
A.
The patient experiences decreased frequency of migraine headaches.
B.
The patient does not experience any more migraine headaches.
C.
The patient reports the termination of the migraine headache after the drug is administered.
D.
The patient experiences increased nausea associated with the migraine headache.
The correct answer and Explanation is :
The correct answer is C. The patient reports the termination of the migraine headache after the drug is administered.
Explanation:
Sumatriptan is a type of triptan medication commonly used for treating acute migraine attacks. The primary goal of triptans is to relieve the symptoms of a migraine attack once it has started. They work by agonizing specific serotonin receptors (5-HT_1B and 5-HT_1D) which causes vasoconstriction of cranial blood vessels and decreases the release of pro-inflammatory neuropeptides, thus alleviating migraine symptoms.
When assessing the effectiveness of sumatriptan, the most direct indicator of its therapeutic effect is whether the medication promptly relieves the symptoms of a migraine attack. Therefore, option C, where the patient reports the termination of the migraine headache after administration of the drug, is the most relevant measure of the drug’s effectiveness. It indicates that the drug is working as intended to abort the migraine episode.
Let’s review the other options briefly:
- A. The patient experiences decreased frequency of migraine headaches: This option is less specific to the immediate effect of the medication. Decreased frequency of migraines might indicate overall effectiveness in reducing the number of migraine episodes over time, but it doesn’t directly measure the acute response to a single dose of sumatriptan.
- B. The patient does not experience any more migraine headaches: This might suggest a complete response to the medication, but it’s less precise. Since sumatriptan is meant to treat acute attacks rather than prevent them, the complete cessation of all future migraines after a single dose is not a standard measure of its effectiveness.
- D. The patient experiences increased nausea associated with the migraine headache: Increased nausea is not a desired effect of sumatriptan and may indicate a side effect rather than a therapeutic response.
In summary, the direct assessment of whether the migraine headache has ended following administration of sumatriptan (option C) is the best indicator of the therapeutic effect, as it confirms that the drug has successfully terminated the acute migraine episode.